Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial
Progress in Cardiovascular Diseases · 2026-11
DOI: 10.1016/j.pcad.2026.10.009 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Progress in Cardiovascular Diseases, 2026-11. Verfasst von Kaibo Hu und 26 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Medicine Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Di…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Patients with anatomically complex coronary artery disease may be considered more suitable for coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI), but some undergo PCI because of clinical constraints and experience higher long-term cardiovascular risk. The physiological rationale underlying this excess post-PCI risk remains unclear. From the perspective of post-PCI revascularization completeness and physiological results, we sought to explain the drivers of excess long-term adverse risk among patients with Favor CABG anatomy undergoing PCI. METHODS: Coronary physiology based on quantitative flow ratio (QFR) was retrospectively evaluated in the randomized PANDA III trial in which all patients underwent PCI. Patients were stratified into 2 predefined groups by baseline SYNTAX score: Favor PCI or Favor CABG. Functional revascularization completeness was assessed using classic residual functional SYNTAX score (c-rFSS). Final physiological results were quantified by post-PCI QFR. Causal mediation analyses used 2-year major adverse cardiovascular events (MACE) excluding periprocedural MI as the outcome to estimate the proportion of the group-outcome association statistically accounted for by residual coronary physiological profiles. The primary endpoint was 2-year MACE, defined as the composite of all-cause death, all MI, or any ischemia-driven revascularization. RESULTS: A total of 1555 patients with complete post-PCI physiological assessment constituted the final study cohort, among whom 269 (17.3%) individuals were stratified to Favor CABG group by baseline SYNTAX score. The 2-year MACE rate was significantly higher in the Favor CABG than the Favor PCI group (18.6% vs 9.2%; adjusted HR: 1.78; 95% CI: 1.27-2.50). Functional incomplete revascularization (c-rFSS >0) was substantially more prevalent among patients in the Favor CABG group (53.2% vs. 15.1%, P < 0.001). Suboptimal post-PCI physiology defined by QFR
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiometabolic Medicine Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…
- Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College,…
- Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Medical Research and Biometrics Centre, National Centre for Cardiovascular Diseases, Beijing, China.
- State Key Laboratory for Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Hu, K., Xu, H., Li, B., Wang, H., Yuan, S., Wu, S., Guan, C., Song, C., Gao, G., Yang, M., An, T., Zhao, Z., Wang, H., Zhao, Y., Liu, W., Jia, L., Liu, Q., Wang, C., Wu, C., …, & Dou, K. (2026). Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.10.009
Vancouver
Hu K, Xu H, Li B, Wang H, Yuan S, Wu S, et al. Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.10.009
BibTeX
@article{Hu2026,
author = {Hu, Kaibo and Xu, Han and Li, Bowen and Wang, Haoyu and Yuan, Sheng and Wu, Shaoyu and Guan, Changdong and Song, Chenxi and Gao, Guofeng and Yang, Min and An, Tao and Zhao, Zhiyong and Wang, Hao and Zhao, Yanyan and Liu, Weida and Jia, Lei and Liu, Qianqian and Wang, Chunyue and Wu, Chao and Song, Weihua and Wang, Hongjian and Song, Lei and Feng, Lei and Zhu, Chenggang and Yin, Dong and Zhang, Rui and Dou, Kefei},
title = {Residual physiological profiles in patients with CABG- or PCI-Favored coronary anatomy: A post hoc analysis of the PANDA III randomized clinical trial},
journal = {Progress in Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.pcad.2026.10.009}
}
EUVIMED